Blood Preparation Market will exceed over USD 75 billion by 2025; as per a new research report.

Growing number of baby boomers susceptible to suffer from chronic diseases such as liver cirrhosis and rising prevalence of blood related conditions will drive blood preparation market over the forecast timeframe. Rising awareness regarding blood donation and several efforts undertaken by government in developing countries such as India to surge number of blood donations should further propel industry growth.

Industry players are heavily investing in development of oral anticoagulants and anti-thrombotic drugs should positively impact business growth. Strong product pipeline offers lucrative growth opportunities in foreseeable future. Application of blood derivatives in aesthetic procedures such as anti-aging treatment will stimulate industry expansion.

Rising incidences of road accidents and trauma cases should drive industry growth. Furthermore, growing prevalence of infectious diseases such as dengue fever leads to surge in demand of blood components such as platelets will positively impact blood preparation market. However, risk of infection post blood transfusion will hinder industry expansion to certain extent over the analysis period.

Anti-thrombotic and anticoagulants market will witness significant growth during the forecast period to reach over USD 30 billion by 2025. High prevalence of conditions such as venous thrombosis coupled with heavy investment companies into research and development of anticoagulant drugs will drive anticoagulants market over the coming years.

Thrombocytosis application segment dominated the global blood preparation industry in 2018 by accounting for more than 25% market share. High incidence of thrombocytosis will surge market growth during the analysis period. Patients suffering with chronic kidney disease are at elevated risk of suffering from thrombosis leading to surge in demand for anticoagulants will positively impact industry growth.

U.S. blood preparation market is anticipated to experience growth of 3.1% CAGR during the forecast timeframe. High awareness levels coupled with growing adoption of aesthetic procedures resulting in increased rates of surgeries and aesthetic therapies will drive U.S. blood preparation market.

Japan blood preparation market will grow significantly over the coming years to reach over USD 4.0 billion by 2025. Growing geriatric population base and numerous initiatives undertaken by Japanese government to allow secure supply of blood should impel Japan blood preparation market growth.

Some of the major market players involved in global blood preparation market are GlaxoSmithKline, Bristol-Myers Squibb, AstraZeneca, Bayer, Leo Pharma, Aralez Pharmaceuticals, Pfizer, Ionis Pharmaceuticals, Daiichi Sankyo, Boehringer Ingelheim, Johnson and Johnson among other players. Firms are focusing on development of innovative oral anti-thrombotic and anti-coagulants to fortify their product base and market reach over the coming years.